Biocure Technology Inc (CURE.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
May 03, 16:00
Biocure Technology Free Cash Flow (Quarterly): -0.0062M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.0062M |
| June 30, 2023 | -0.0139M |
| March 31, 2023 | -0.2468M |
| December 31, 2022 | -0.1755M |
| September 30, 2022 | -0.0882M |
| June 30, 2022 | -0.1706M |
| March 31, 2022 | -0.384M |
| December 31, 2021 | -0.1108M |
| September 30, 2021 | -0.6923M |
| June 30, 2021 | -0.1131M |
| March 31, 2021 | -0.1673M |
| December 31, 2020 | -0.3879M |
| September 30, 2020 | -0.1882M |
| June 30, 2020 | -0.3195M |
| March 31, 2020 | -0.4174M |
| December 31, 2019 | -1.097M |
| September 30, 2019 | -0.8638M |
| June 30, 2019 | -0.6831M |
| March 31, 2019 | -1.087M |
| December 31, 2018 | -0.9255M |
| September 30, 2018 | -0.4719M |
| June 30, 2018 | -1.113M |
| March 31, 2018 | -1.018M |
| December 31, 2017 | |
| September 30, 2017 | -0.0158M |
| Date | Value |
|---|---|
| June 30, 2017 | -0.008M |
| September 30, 2016 | -0.0116M |
| June 30, 2016 | -0.0078M |
| March 31, 2016 | -0.0017M |
| December 31, 2015 | -0.0073M |
| September 30, 2015 | -0.0092M |
| June 30, 2015 | -0.0078M |
| March 31, 2015 | -0.0026M |
| December 31, 2014 | -0.0076M |
| September 30, 2014 | -0.0155M |
| June 30, 2014 | -0.0111M |
| March 31, 2014 | 0.0733M |
| December 31, 2013 | -0.0844M |
| September 30, 2013 | -0.0216M |
| June 30, 2013 | 0.0012M |
| March 31, 2013 | -0.049M |
| December 31, 2012 | -0.018M |
| September 30, 2012 | -0.1986M |
| June 30, 2012 | 0.2034M |
| March 31, 2012 | -0.0909M |
| December 31, 2011 | -0.0239M |
| September 30, 2011 | -0.0311M |
| June 30, 2011 | -0.0664M |
| March 31, 2011 | |
| December 31, 2010 |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.097M
Minimum
Dec 2019
-0.0062M
Maximum
Sep 2023
-0.3403M
Average
-0.2175M
Median
Free Cash Flow (Quarterly) Benchmarks
| Core One Labs Inc | -- |
| Nova Mentis Life Science Corp | -- |
| Nanosphere Health Sciences Inc | -0.0359M |
| Lobe Sciences Ltd | -0.0948M |
| Algernon Pharmaceuticals Inc | -- |